BOULDER, Colo., April 1, 2026 /CNW/ - On March 31, 2026 following completion of the Transaction (as defined below), Ben Atkins (the "Acquiror") acquired control and direction of a total of 6,719,240 subordinate voting shares ("SVS") in the capital of TelyRx Holdings Inc., formerly known as Apolo V Acquisition Corp. ("TelyRx" or the "Company").
On March 31, 2026, the Company completed the proposed transaction contemplated by the business combination agreement dated January 19, 2026, as amended (the "Business Combination Agreement") involving TelyRx, Inc., TelyRx Finco Inc., 1001474388 Ontario Inc. and Apolo V MergerCo Inc to complete a go-public transaction for TelyRx, Inc. (the "Transaction"). The Transaction constitutes Apolo V Acquisition Corp.'s "Qualifying Transaction" under Policy 2.4 – Capital Pool Companies of TSX Venture Exchange (the "TSXV").
In connection with the Transaction, as more fully described in Apolo V Acquisition Corp.'s filing statement (the "Filing Statement") dated March 24, 2026, the parties completed a series of steps (as defined in the Filing Statement) including the following: TelyRx Private Placement; Consolidation; Share Capital Reorganization; conversion of Subscription Receipts; Amalgamation and Merger.
Prior to the closing of the transactions contemplated by the Business Combination Agreement and Filing Statement, the Acquiror did not hold any securities of TelyRx.
Following closing of the transactions contemplated by the Business Combination Agreement and Filing Statement (including a purchase by the Acquiror of 1,245,160 subscription receipts at a price of C$4.50 in connection with the TelyRx Private Placement, for a total purchase price of C$5,603,220.00), the Acquiror acquired control and direction of a total of 6,719,240 SVS. On the basis of 26,353,729 SVS issued and outstanding at closing of the Transaction, the Acquiror holds 25.50% (6,719,240) SVS on a non-diluted basis.
TelyRx's head office is located at 24761 US Highway 19 North, Clearwater, Florida, USA, 33763.
The Acquiror will file an early warning report with the applicable securities regulators in Canada with respect to the foregoing matters pursuant to NI 62-103, a copy of which will be available under the Issuer's profile on SEDAR+ at www.sedarplus.ca. A copy of the early warning report can be obtained by contacting the Acquiror by phone at 727-224-9874. The address for the acquiror is 900 Pearl St., Suite 300, Boulder, Colorado, USA, 80302.
SOURCE Ben Atkins
Share this article